Eloise Kuijer, our PhD student with Dr Chris Bailey, Professor Sue Wonnacott and Dr Sarah Bailey, Department of Life Sciences, University of Bath, will be presenting the results of her research into the electrophysiological and behavioural effects of activation of kappa opioid receptors at KappaCon 2023, the 7th Conference on the ‘Therapeutic Potential of Kappa Opioids in Pain and Addiction’ to be held 29th to 31st March 2023 at the National Institutes of Health (NIH) Campus, Bethesda, Maryland, USA.
If you are at the meeting please pop along to see her Hot Topic talk or meet her at one of her posters.
Hot topic oral communication, Friday 31st March 3:50 PM
EJ Kuijer, SJ Bailey, DJ Heal, S Smith, S Wonnacott, & CP Bailey Electrophysiological analysis of kappa opioid receptor activation in mouse paraventricular thalamus
Poster 10. EJ Kuijer, SJ Bailey, DJ Heal, S Smith, S Wonnacott, CP Bailey Nalfurafine is aversive in doses that produce equi-effective antinociception to U50,488
Poster 11. EJ Kuijer, SJ Bailey, DJ Heal, S Smith, S Wonnacott, CP Bailey A single injection of kappa opioid receptor agonist inhibits contextual heroin cues by counter-conditioning, not by enhancing extinction